Fesoterodine
- Generic Name
- Fesoterodine
- Brand Names
- Toviaz
- Drug Type
- Small Molecule
- Chemical Formula
- C26H37NO3
- CAS Number
- 286930-02-7
- Unique Ingredient Identifier
- 621G617227
Overview
Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.
Background
Fesoterodine is an antimuscarinic prodrug for the treatment of overactive bladder syndrome.
Indication
适用于治疗急迫性尿失禁和膀胱过度活动综合征患者的尿频、尿急、尿失禁或所有这些症状组合。
Associated Conditions
- Neurogenic Detrusor Overactivity
- Overactive Bladder Syndrome (OABS)
Clinical Trials
FDA Approved Products
Fesoterodine Fumarate
Manufacturer:Amneal Pharmaceuticals LLC
Route:ORAL
Strength:4 mg in 1 1
Approved: 2021/11/08
NDC:65162-369
Fesoterodine Fumarate
Manufacturer:ANI Pharmaceuticals, Inc.
Route:ORAL
Strength:8 mg in 1 1
Approved: 2023/01/04
NDC:62559-376
fesoterodine fumarate
Manufacturer:Zydus Pharmaceuticals USA Inc.
Route:ORAL
Strength:8 mg in 1 1
Approved: 2024/04/02
NDC:68382-480
Fesoterodine Fumarate
Manufacturer:Alembic Pharmaceuticals Inc.
Route:ORAL
Strength:4 mg in 1 1
Approved: 2023/01/10
NDC:62332-175
Fesoterodine Fumarate
Manufacturer:Alembic Pharmaceuticals Inc.
Route:ORAL
Strength:8 mg in 1 1
Approved: 2023/01/10
NDC:62332-176
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath